HCPCS Level IIdrugActive
J7185
Xyntha inj
BETOS: O1E
Effective: 2010-01-01
Referenced in 5 policies
Description
Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Xyntha
Manufacturer
Pfizer Inc
HCPCS Dosage
1 IU
Billing Units
1.0000
9
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.